Skip Ribbon Commands
Skip to main content

​COVID-19 Vaccine

The CDC is recommending a new COVID-19 booster that targets the BA.4 and BA.5 subvariants of the Omicron variant. The new "bivalent" formulation of the Pfizer vaccine is recommended as a booster for individuals ages 5 and older, and the new "bivalent" formulation of the Moderna vaccine is recommended as a booster for individuals ages 6 and older. Read the October 12 news release from the CDC for more information.

Visit an MCPH clinic or local pharmacy to get your bivalent booster and flu shot. MCPH clinic locations and hours are listed below.
get the facts and get vaccinated


COVID-19 Vaccine Recommendations

The US Centers for Disease Control and Prevention (CDC) recommends the Pfizer and Moderna COVID-19 vaccines for everyone aged 6 months and older and the new two-dose Novavax COVID-19 vaccine for individuals aged 12 and older, including pregnant women and people with compromised immune systems.

The CDC recommends the new bivalent formualtions of the Pfizer and Moderna vaccines as boosters that are effective against the Omicron variants circulating now:

  • The new Pfizer and Moderna vaccines’ bivalent formulas (which contain mRNA parts of the Omicron BA.4 and BA.5 subvariants in addition to mRNA parts from the original strain of the coronavirus) given as a single booster dose at least 2 months after the last dose of the primary vaccine series or booster dose for individuals 5 years of age and older for Pfizer and individuals 6 years of age and older for Moderna.
  • The original Pfizer and Moderna vaccines’ monovalent formulas (which contain mRNA parts of only the original strain of the coronavirus) are no longer given as booster doses for individuals 5 years of age and older. The original Pfizer and Moderna vaccines will continue to be given as the primary series vaccines for individuals ages 6 months and older.

See the COVID-19 Vaccine Schedule for Most People table and COVID-19 Vaccine Schedule for People Who are Immunocompromised table below to see recommended vaccine types and appropriate dosing schedule for most people, including children, and for people with compromised immune systems.


Find the COVID-19 Vaccine Near You

  • The map below shows the locations of providers offering COVID-19 vaccines, testing, and treatment in Mecklenburg County.

  • Both MCPH clinic locations currently offer the Pfizer, Moderna, and Novavax COVID-19 vaccines. Walk in during the hours listed below or call 704-336-6500 to make an appointment:

Northwest Health Department2845 Beatties Ford Road
Mon, Tues, Thurs, Fri: 8:30 am - 11:30 am; 1:00 pm - 4:30 pm
Wed: 10:30 am - 1:30 pm; 3:00 pm - 6:30 pm

Southeast Health Department249 Billingsley Road
Mon, Tues, Thurs, Fri: 8:30 am - 11:30 am; 1:00 pm - 4:30 pm
Wed: 10:30 am - 1:30 pm; 3:00 pm - 6:30 pm

 

map menu button   Press the map menu button to view the map key and additional functionality.
   Open map in new window

COVID-19 Vaccine Information

The primary series of the vaccine, followed by booster doses, protects against severe COVID-19 illness, hospitalization, and death by triggering your body to make antibodies against the SARS-CoV-2 virus that causes COVID-19 illness. Vaccine immunity is long lasting and safe. SARS-CoV-2 infection also triggers your body to make antibodies against re-infection, but that natural immunity is temporary (about 90 days) and comes with the risk of severe illness, hospitalization, and death.

Visit the links below for information about the COVID-19 vaccines:


COVID-19 Vaccination Schedule for Most People
Manufacturer Age Group Dose 1 Dose 2 Dose 3
Pfizer-BioNTech / COMIRNATY

(mRNA vaccine type)
6 months - 4 years Initial dose
(primary series)
3 - 8 weeks after Dose 1
(primary series)
At least 8 weeks after Dose 2
(primary series)
5+ years Initial dose
(primary series)
3 - 8 weeks after Dose 1
(primary series)
At least 2 months after Dose 2
(bivalent booster)
Moderna / Spikevax

(mRNA vaccine type)
6 months - 5 years Initial dose
(primary series)
4 - 8 weeks after Dose 1
(primary series)
6+ years Initial dose
(primary series)
4 - 8 weeks after Dose 1
(primary series)
At least 2 months after Dose 2
(bivalent booster)
Novavax COVID-19 Vaccine, Adjuvanted

(protein subunit vaccine type)
12-17 years Initial dose
(primary series)
3 - 8 weeks after Dose 1
(primary series)
At least 2 months after Dose 2
(bivalent booster)
18+ years Initial dose
(primary series)
3 weeks after Dose 1
(primary series)
At least 2 months after Dose 2
(bivalent booster)
OR
At least 6 months after Dose 2
(monovalent booster)
Janssen / Johnson & Johnson*

(viral vector vaccine type)
18+ years Initial dose
(primary series)
At least 2 months after Dose 1
(bivalent booster)
* Age-appropriate Pfizer or Moderna COVID-19 vaccines are preferred over the Janssen COVID-19 vaccine for primary and booster vaccination. Janssen COVID-19 vaccine should only be used in limited situations.

COVID-19 Vaccination Schedule for People Who are Immunocompromised
Manufacturer Age Group Dose 1 Dose 2 Dose 3 Dose 4
Pfizer-BioNTech / COMIRNATY

(mRNA vaccine type)
6 months - 4 years Initial dose
(primary series)
3 weeks after Dose 1
(primary series)
At least 8 weeks after Dose 2
(primary series)
5+ years Initial dose
(primary series)
3 - 8 weeks after Dose 1
(primary series)
At least 4 weeks after Dose 2
(primary series)
At least 2 months after Dose 3
(bivalent booster)
Moderna / Spikevax

(mRNA vaccine type)
6 months - 5 years Initial dose
(primary series)
4 weeks after Dose 1
(primary series)
At least 4 weeks after Dose 2
(primary series)
6+ years Initial dose
(primary series)
4 weeks after Dose 1
(primary series)
At least 4 weeks after Dose 2
(primary series)
At least 2 months after Dose 3
(bivalent booster)
Novavax COVID-19 Vaccine, Adjuvanted

(protein subunit vaccine type)
12-17 years Initial dose
(primary series)
3 weeks after Dose 1
(primary series)
At least 2 months after Dose 2
(bivalent booster)
18+ years Initial dose
(primary series)
3 weeks after Dose 1
(primary series)
At least 2 months after Dose 2
(bivalent booster)
OR
At least 6 months after Dose 2
(monovalent booster)
Janssen / Johnson & Johnson*

(viral vector vaccine type)
18+ years Initial dose
(primary series)
At least 4 weeks after Dose 1
(additional Pfizer or Moderna dose)
At least 2 months after Dose 2
(bivalent booster)
* Age-appropriate Pfizer or Moderna COVID-19 vaccines are preferred over the Janssen COVID-19 vaccine for primary and booster vaccination. Janssen COVID-19 vaccine should only be used in limited situations.

WE'RE HERE TO ANSWER YOUR QUESTIONS

Public Health Hotline: 980-314-9400

Option 3 (English) or Opción 8 (Español)

Monday-Friday, 8 a.m. - 5 p.m.

This hotline is for general questions regarding COVID-19 and vaccines.
If you have a medical emergency, call 911.